COPSII: ROLE OF TELEMEDICINE STRATEGIES IN LAW ENFORCEMENT OFFICERS WITH OBSTRUCTIVE SLEEP APNEA

COPSII: ROLE OF TELEMEDICINE STRATEGIES IN LAW ENFORCEMENT OFFICERS WITH OBSTRUCTIVE SLEEP APNEA

Brief description of study

This trial is looking for members of the Philadelphia police force who may have a medical condition called obstructive sleep apnea (OSA). If you have sleep apnea, your throat may close partly or completely during sleep, which causes oxygen levels in your blood to fall briefly. This can cause symptoms such as snoring, gasping, frequent awakenings, and morning headaches. 

The purpose of the study is to do the following: 1) To evaluate a new program to manage sleep apnea, which uses software to track your CPAP use so that patients get the greatest possible benefit from treatment (U-Sleep, ResMed, Inc.) 2) To measure symptoms and possible outcomes of sleep apnea, including: daytime sleepiness, falling asleep during meetings, work related accidents, administrative errors, fatigue-related safety violations, anger toward suspects that is difficult to control, and being absent from work.

Detailed description of study

To be eligible for this study you must: be employed as Philadelphia law enforcement, have been on the force for at least the past 2 years, and plan to remain on the force for at least the next 2 years. You may be previously diagnosed with sleep apnea, but only if you have not received treatment for said diagnosis in the past 3 months. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Obstructive Sleep Apnea (OSA),Sleep Apnea
  • Age: Between 18 Years - 85 Years
  • Gender: All

on the force for > 2 years

plan to remain on force for > 2 years

exhibit symptoms of sleep apnea (will be tested for sleep apnea by the study team)

employed by the Philadelphia Police Department 

Updated on 09 Mar 2024. Study ID: 833626

Find a site

What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center